The global cell-based assays market size was valued at USD 24.95 billion in 2025 and is expected to reach USD 43.51 billion by 2033, at a CAGR of 7.20% during the forecast period
The market growth is largely fueled by rapid advancements in cell biology research, increasing adoption of high-throughput screening techniques, and the growing demand for reliable, reproducible, and sensitive assay systems in drug discovery and development
Furthermore, rising investment from pharmaceutical and biotechnology companies, coupled with expanding applications in oncology, immunology, and toxicology studies, is establishing cell-based assays as a critical tool in preclinical and clinical research. These converging factors are accelerating the uptake of cell-based assay solutions, thereby significantly boosting the market’s growth